A Novel CD34-Specific T-cell Engager Efficiently Depletes Acute Myeloid Leukemia and Leukemic Stem Cells In Vitro and In Vivo

By
Justin.choi
-
0
173
Researchers designed a CD34/CD3 bispecific T-cell engager (BiTE) and characterized its anti-leukemia potential in vitro, ex vivo and in vivo.
[Haematologica]

Sorry, but the selected Zotpress account can't be found.

Abstract